Please do not adjust margins
Organic & Biomolecular Chemistry
Page 4 of 5
COMMUNICATION
Journal Name
catalyzed by I(III) reagents generated in DsiOtuI:.10T.h10e39re/Da0cOtiBo0n06a1ls2oB
proceeded smoothly using stoichiometric I(III) reagents, and
underwent selective transformation when substrates 1aj and
1ak were used. Further investigations into the application of
these products are ongoing in our laboratory.
We are grateful for the financial support from the National
Science and Technology Major Project of China on “Key New
Drug Creation and Development Program” (Project No.
2014ZX09J14104-06C), and the Shaanxi Province Key Research
and Development Program (S2019-YFZDCXL-ZDLSF-0138).
Scheme 5 Control experiments. a I: 1H NMR (400 MHZ) spectra of
reaction mixture of 1a (0.05 mmol), I6 (10 mol%), and mCPBA
Conflicts of interest
(0.075 mmol) in CD3CN (0.5 mL) with CH2Br2 (2.5 L) as There are no conflicts to declare.
internal standard. II: BF3·Et2O (0.075 mmol) was added to the
NMR tube; III: for 12 min; IV: for 22 min; V: for 30 min.
Notes and references
2a
1
(a) R. E. Royer, R. G. Mills, S. A. Young and D. L. V. Jagt,
mCPBA
Pharmacol. Res.,1995, 31, 49; (b) Y. Yu, J. A. Deck, L. A.
Hunsaker, L. M. Deck, R. E. Royer, E. Goldberg and J. D.
Vander, Biochem. Pharmacol., 2001, 62, 81; (c) S. G. Hegde,
R. D. Bryant, L. F. Lee, S. K. Parrish and W. B. Parker, Cyclic
ArI
CBA
m
RCO2H
RO2C
CO2R
Imidate
Derivatives
of
5-Amino-2,6-
I
Ph
H
HN
bis(polyfluoroalkyl)pyridine-3-carboxylates,
Chemical Society: Washington, DC, 1995, p. 60.
American
Ar
O
2
(a) K. Kurita, Y. Suzuki, T. Enari, S. Ishii and S. Nishimura,
Macromolecules, 1995, 28, 1801; (b) C. D. Georgiou, D.
Zisimopoulos, V. Argyropoulou, E. Kalaitzopoulou, P. V.
Ioannou, G. Salachas and T. Grune, Redox Biology, 2018, 17,
236.
Y. Ito, H. Kato and T. Saegusa, J. Org. Chem., 1982, 47, 741.
(a) H. Yoshida, H. Fukushima, J. Ohshita and A. Kunai, Angew.
Chem., Int. Ed., 2004, 43, 3935; (b) H. Yoshida, H. Fukushima,
T. Morishita, J. Ohshita and A. Kunai, Tetrahedron, 2007, 63,
4793; (c) K. M. Allan, C. D. Gilmore and B. M. Stoltz, Angew.
Chem., Int. Ed., 2011, 50, 4488; (d) Y. Nishihara, J. Li, S.
Noyori, M. Iwasaki and K. Nakajima, Heterocycles, 2012, 86,
933; (e) J. Li, S. Noyori, K. Nakajima and Y. Nishihara,
Organometallics, 2014, 33, 3500.
(a) C. G. Saluste, S. Crumpler, M. Furber and R. J. Whitby,
Tetrahedron Lett., 2004, 45, 6995; (b) X.-D. Fei, Z.-Y Ge, T.
Tang, Y.-M. Zhu and S.-J. Ji, J. Org. Chem., 2012, 77, 10321.
(a) C. Schlemmer, L. Andernach, D. Schollmeyer, B. F. Straub
and T. Opatz, J. Org. Chem., 2012, 77, 10118; (b) S. Mehta, T.
Yao and R. C. Larock, J. Org. Chem., 2012, 77, 10938; (c) R.
Mancuso, I. Ziccarelli, D. Armentano, N. Marino, S. V. Giofrè
and B. Gabriele, J. Org. Chem., 2014, 79, 3506; (d) X. Bantreil,
A. Bourderioux, P. Mateo, C. E. Hagerman, M. Selkti, E.
Brachet and P. Belmont, Org. Lett., 2016, 18, 4814; (e) D.
Ding, T. Mou, J. Xue and X. Jiang, Chem. Commun., 2017, 53,
5279; (f) Y. Wang, B. Ouyang, G. Qiu, H. Zhou and J. Liu, Org.
Biomol. Chem., 2019, 17, 4335.
BF3
O
1a
I
RCO2H
O
IM2
Ar
R
BF3
Ph
O
HN
BF3.Et2O
3
4
BF3.Et2O
O2CR
I
IM1
Ar
Scheme 6 Plausible reaction mechanism.
radical process was unlikely. Dioxygenation product 2a’ was
obtained in 73% yield by performing the reaction in the
presence of TsOH·H2O (Scheme 5a), which indicated the
5
6
1
important role of BF3·Et2O in this reaction. And dynamic H
NMR study well monitored the reaction progress (Scheme 5b).
Based on these results, a tentative reaction mechanism was
proposed (Scheme 6). Mechanistically, ArI is activated by
mCPBA, generating a free coordination site at the I(III) center.
BF3 then facilitates ligand exchange and I(III) reacts with the
double bond to construct three-membered iodonium ion
intermediate IM1, which is the prerequisite step. Species IM1
is then attacked by amide oxygen as the O–nucleophile to give
intermediate IM2. Finally, IM2 undergoes rapid reductive
elimination to afford oxy-cyclization product 2a and
regenerate active catalyst ArI, completing the catalytic cycle. In
this case, BF3 coordination converts the acyloxy group into a
strong leaving group, which promotes the reductive
elimination step.
7
8
(a) K. Tani and B. M. Stoltz, Nature, 2006, 441, 731; (b) C. R.
Kemnitz and M. J. Loewen, J. Am. Chem. Soc., 2007, 129,
2521.
For N-5-exo-dig products obtained using other methods: (a) J.
Ju, C. Qi, L. Zheng and R. Hua, Tetrahedron Lett., 2013, 54,
5159; (b) B. Gao, S. Liu, Y. Lan and H. Huang, Organometallics,
2016, 35, 1480; (c) Z. Wang, F. Zhu, Y. Li and X. Wu,
ChemCatChem., 2017, 9, 94; (d) A. El-Harairy, Yiliqi, B. Lai, L.
Vaccaro, M. Li and Y. Gu, Adv. Synth. Catal., 2019, 361, 3342.
(a) X. Shang, L. Xu, W. Yang, J. Zhou, M. Miao and H. Ren, Eur.
J. Org. Chem., 2013, 5475; (b) T. Takesue, M. Fujita, T.
In conclusion, we have presented a useful method for the
9
synthesis
of
various
benzoiminolactones
through
4 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins